I hope Tuttle is taking a hard look at the sales force. To hire 35 direct as was stated here is suicide unless a company has a product in huge demand. The cost will eat TBIO alive. I cannot believe they did not do a couple of market tests before basically staking the company. People do not believe TBIO will be cash flow positive from this point on with the huge sales nut to cover. $1.0 per territory in sales; doubt it will be close. Independent reps would have worked very well if the product is as advertised. Problem is that long term shareholders have taken it on the chin thru newly issued shares and debt to cover the gross mismanagement. Who gets the benefit if TBIO goes up strong? Biotech managers have to learn how to run a company with very little money. Many universities and foundations who will co-op research. But, 35 direct sales people? Come on; where in the hell is the BOD?
Even if they did hit $1mm in GROSS sales, the margins are slimming, and their guaranteed comp is high. Plus, they now have a massive "Sales Management" team. It would be nearly impossible to break even with this structure.